Taevas
Taevas Global provides compliant, temperature-controlled warehousing and real-time inventory management for pharmaceutical, medtech, and life sciences organizations operating across global markets.
Warehousing and inventory management in life sciences is far more than storage. It encompasses regulatory compliance, cold chain integrity, serialization, and real-time stock visibility across complex multi-market distribution networks. For doctors, hospital procurement teams, and distributors, the reliability of every shipment depends on the precision of what happens in the warehouse.
Taevas Global brings a purpose-built approach to life sciences warehousing, combining GMP-compliant facilities, advanced warehouse management systems, and dedicated inventory analysts to give clients continuous visibility and control. Our model is designed to reduce stock-outs, minimize waste, and ensure every product reaches its destination in full compliance with local and international regulations.
Clients gain end-to-end inventory confidence — from receipt to final-mile delivery — backed by audit-ready documentation and real-time dashboards.
Temperature-controlled and ambient storage facilities meeting WHO, EU GMP, and FDA standards. Every zone is monitored continuously to protect product integrity.
Cloud-based warehouse management systems provide live stock visibility across all SKUs and locations. Procurement teams and distributors access dashboards 24/7.
End-to-end serialization services ensure compliance with track-and-trace mandates in all major regulated markets. Full chain-of-custody documentation is maintained automatically.
Data-driven reorder algorithms minimize overstock and prevent critical shortages. Inventory levels are continuously optimized against actual consumption patterns.
Our warehousing and inventory framework is built on six interconnected pillars that together ensure product availability, regulatory compliance, and supply chain resilience for life sciences organizations worldwide.
All warehousing operations adhere to GDP, GMP, and applicable local regulations in every market we serve. Facilities undergo regular third-party audits and are inspection-ready at all times. Clients receive full documentation packages for regulatory submissions and procurement tenders.
Dedicated cold chain infrastructure maintains 2-8C, -20C, and ultra-low temperature zones with continuous monitoring and automated alerts. Every temperature excursion is logged, assessed, and escalated per client SOPs. Cold chain mapping and validation reports are provided for each product family.
Proprietary warehouse management technology delivers real-time stock positions, expiry tracking, and lot-level traceability across all storage locations. Customizable dashboards give procurement teams, distributors, and logistics managers instant access to actionable data. Historical analytics support demand forecasting and safety stock optimization.
Flexible warehousing models scale with seasonal demand spikes, product launches, and market expansions without long-term fixed commitments. Capacity is dynamically allocated across our global network to match client growth trajectories. This agility reduces capital expenditure while maintaining service levels.
Inventory is positioned strategically across regional hubs to minimize lead times and customs delays in over 120 countries. Country-specific labeling, documentation, and import compliance are managed in-house. Distributors benefit from pre-cleared, market-ready stock that accelerates time to shelf.
Monthly KPI reports cover fill rates, order accuracy, inventory turns, and shrinkage metrics benchmarked against industry standards. Root-cause analysis and corrective action plans are embedded into every client engagement. Continuous improvement cycles ensure warehousing performance evolves with client needs.
A structured four-stage process that balances speed with rigour — typically complete in 4–6 weeks.
We align on objectives, geographies, therapy areas, and the specific business questions that need answering.
A 30–45 minute scoping call establishes the intelligence framework — ensuring every subsequent research hour is focused on decisions that matter.
Our warehousing and inventory capabilities are tailored to the distinct regulatory, handling, and distribution requirements of every major life sciences sector.
From branded generics to biologics, we cover the full pharmaceutical value chain — clinical pipeline tracking, patent cliff analysis, and reimbursement modelling across regulated and emerging markets.
Our warehousing and inventory network spans every major life sciences market, with regional hubs positioned to minimize lead times and ensure compliant, market-ready distribution.
India · China · Japan · South Korea · Australia · Indonesia · Thailand · Vietnam · Philippines
Germany · France · UK · Italy · Spain · Netherlands · Switzerland · Poland · Sweden
United States · Canada · Brazil · Mexico · Colombia · Argentina · Chile
UAE · Saudi Arabia · Turkey · Israel · Egypt · Qatar
South Africa · Nigeria · Kenya · Ethiopia · Morocco
Bangladesh · Sri Lanka · Pakistan · Nepal · Myanmar
Every Taevas warehousing and inventory engagement includes a comprehensive set of operational, compliance, and reporting deliverables designed to give life sciences clients complete confidence in their supply chain.
TAM/SAM/SOM with 5-year projections, segmented by product type, end user, and geography.
Profiling of top 10–15 players with pipeline, financials, positioning, and SWOT analysis.
Step-by-step approval guide, typical timelines, required dossiers, and local partner requirements.
Benchmark pricing across channels, reimbursement eligibility, and HTA decision landscape.
Prioritised strategy with recommended partnerships, channels, and launch sequencing.
Key opinion leaders, payer organisations, and the distributor ecosystem across target markets.
Interactive data visualisation summarising findings for C-suite and board presentations.
Post-delivery support to clarify findings, run scenario analyses, or refine recommendations.
Our warehousing and inventory services are designed for the specific operational and strategic needs of the professionals who keep life sciences supply chains moving.
Evaluating new market entry, product launches in new geographies, or acquisitions requiring deep commercial due diligence.
Conducting commercial due diligence, validating market size assumptions, or assessing competitive moats before committing capital.
Seeking investor-grade market data to underpin fundraising narratives, identify first-mover opportunities, or prioritise expansion.
Understanding sector landscapes, benchmarking policy environments, and identifying foreign investment opportunities in health and life sciences.
Translating academic research into commercial potential assessments, technology transfer opportunities, and licensing strategy.
White-label intelligence support for strategy and management consulting firms advising clients across life sciences markets.
Our analysts work exclusively in pharma, medtech, and consumer health. Every report reflects deep domain expertise — not generic research methodology applied to healthcare.
We don’t just aggregate public data. Every engagement includes primary interviews with regulators, KOLs, payers, and channel partners — intelligence you can’t Google.
Our network spans India, Southeast Asia, MENA, and Sub-Saharan Africa — markets that generic firms cover superficially but where the greatest growth opportunities exist.
We write for decision-makers, not archives. Every report includes a clear recommendation. Our readout sessions are structured for board discussions, not just information transfer.
Rapid-response turnarounds of 2–4 weeks for focused engagements — without sacrificing the rigour of primary research and expert validation.
Our 30-day Q&A window, ongoing subscriptions, and retainer models mean we’re a long-term intelligence partner — not a one-off vendor.
“Taevas transformed our inventory operations across 14 markets in under six months. The combination of real-time visibility, GDP compliance, and proactive account management gave our procurement and quality teams a level of confidence we had never experienced with a third-party logistics provider.”
Warehousing and inventory management is the operational foundation — pair it with these complementary Taevas services to build a fully integrated life sciences supply chain strategy.
From regulatory pathway mapping to full dossier preparation and submission management across global markets.
Shortlisting, evaluating, and connecting you with validated in-market partners, distributors, and licensing candidates.
Optimise launch pricing, reimbursement positioning, and access pathways to maximise commercial success from day one.
Scientific communication strategy, publication planning, and structured KOL engagement programmes for new market entrants.
Investor-grade commercial assessments for M&A, licensing deals, or fundraising — with rapid turnaround for live transactions.
Monthly or quarterly market monitoring — competitive signals, regulatory updates, and commercial developments as a managed service.
Connect with our life sciences supply chain team today to discuss your warehousing and inventory requirements. We will design a compliant, scalable solution tailored to your products, markets, and growth objectives.